Nexalin Technology (NXL) Selling, General & Administrative (2021 - 2026)
Powered by 
Analysis
Nexalin Technology (NXL) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | 4.03 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | 617.90 Mn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | 3.20 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 2.23 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 1.80 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 561.20 Mn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | -964.00 Mn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | 358.70 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 369.70 Mn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 | 852,838.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 852,838.00 |
| Mar 31, 2026 | 801,904.00 |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.42 Mn |
| Jun 30, 2025 | 893,836.00 |
| Mar 31, 2025 | 929,220.00 |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 598,757.00 |
| Mar 31, 2024 | 645,719.00 |
| Dec 31, 2023 | -401,820.00 |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 479,545.00 |
| Mar 31, 2023 | 344,953.00 |
| Dec 31, 2022 | 407,930.00 |
| Sep 30, 2022 | 479,445.00 |
| Jun 30, 2022 | 385,990.00 |
| Mar 31, 2022 | 218,374.00 |
| Dec 31, 2021 | 296,093.00 |
| Sep 30, 2021 | 1.62 Mn |